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  Clinical effects of Ubretid on neurogenic bladder dysfunction were evaluated by cysto－
adaptometry． Oral administration of Ubretid 5 mg daily for 3 weeks made the hypotonic and
the hypertonlc bladders to be normotonic in several cases． This is the noteworthy merit of
Ubretid distinguished from bethanechol chloride， which could not alter the hypertonic bladder
tow，ard normotonic．
  In many traumatic paraplegics （30 in 49）， the serum B－glucuronidase activities were high，
over 300 ptg／dl／hr． This finding was considered as a sign suggesting of abnormal sugar
inetabolism in this disorders．
  By oral administration of Ubretid 5 mg daily for a week the high serum P－glucuronidase
activities in traumatic paraplegics were reduced to normal in many cases （7 in 12）．
  Diagnostic value of high serum P－glucuronidase in traumatic paraplegics， and therapeutic
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3）近藤・内藤・河田・島野：目脂尿会誌，55：
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